Tag: Wellness options
Psychedelic Medicine: Navigating ‘Plan B’ with Insights from Reproductive Health
The Food and Drug Administration’s decision not to approve Lykos Therapeutics’ application for MDMA (a psychedelic drug known on the street as Ecstasy or molly) plus therapy for post-traumatic stress disorder comes as no...